ibandronic acid has been researched along with Recrudescence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TS; Hsu, YC; Kao, FC; Liu, PH; Tu, YK | 1 |
| Burian, E; Ehrenfeld, M; Mahaini, S; Otto, S; Pautke, C; Probst, F; Smolka, W; Troeltzsch, M | 1 |
| Kutilek, S; Nemec, V; Plasilová, I | 1 |
| Bergner, R; Bruckner, D; Henrich, DM; Hoffmann, M; Uppenkamp, M | 1 |
| Body, JJ; Clemens, MR; Degardin, M; Herrmann, Z; Huss, HJ; Manegold, C; Pecherstorfer, M; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M; van Eijkeren, M | 1 |
| Body, JJ; Bundred, N; Clemens, MR; Degardin, M; Eghbali, H; Herrmann, Z; Huss, HJ; Manegold, C; Pecherstorfer, M; Rizzoli, R; Rückert, F; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M | 1 |
2 trial(s) available for ibandronic acid and Recrudescence
| Article | Year |
|---|---|
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
Topics: Adult; Aged; Aged, 80 and over; Bone Resorption; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Nausea; Neoplasms; Recurrence; Regression Analysis; Thrombocytopenia; Treatment Outcome | 1996 |
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
Topics: Absorption; Calcium; Cohort Studies; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Kidney Tubules; Male; Middle Aged; Neoplasms; Parathyroid Hormone-Related Protein; Proteins; Recurrence; Syndrome; Treatment Outcome | 1999 |
4 other study(ies) available for ibandronic acid and Recrudescence
| Article | Year |
|---|---|
Effects of Injected Antiosteoporotic Medication Versus Oral Bisphosphonates on Rates of Repeated Vertebroplasty or Kyphoplasty.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Density Conservation Agents; Denosumab; Drug Therapy, Combination; Female; Fractures, Compression; Humans; Ibandronic Acid; Injections; Male; Middle Aged; Recurrence; Reoperation; Teriparatide; Vertebroplasty; Zoledronic Acid | 2020 |
Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: Pain relief and insight into pathogenesis.
Topics: Adolescent; Adult; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Male; Mandibular Diseases; Middle Aged; Osteomyelitis; Pain; Recurrence; Retrospective Studies; Visual Analog Scale; Young Adult | 2015 |
Once-monthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass.
Topics: Adolescent; Bone and Bones; Bone Density; Bone Density Conservation Agents; Diphosphonates; Fractures, Bone; Humans; Ibandronic Acid; Male; Recurrence | 2012 |
[Therapy of hypercalcemia with ibandronate in case of acute renal failure].
Topics: Acute Kidney Injury; Adenoma; Aged; Bone Density Conservation Agents; Calcium; Creatinine; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Ibandronic Acid; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Recurrence | 2006 |